SEC Form 4 · accession 0001144204-17-026397
CAPRICOR THERAPEUTICS, INC. · CAPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B Musket
Director
Period of report
May 9, 2017
Accepted (ET)
May 11, 2017 · 2:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 9, 2017 | P | 25,000 | $3.10 | A | 25,000 | D | |
| Common StockF2 | holding | — | — | — | 70,962 | I | By SEP FBO David B. Musket |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person entered into a Subscription Agreement with Capricor Therapeutics, Inc. (the "Issuer") pursuant to which the Reporting Person, on May 5, 2017 purchased an aggregate of 25,000 shares of the Issuer's common stock at a purchase price of $3.10 per share for total cash proceeds of approximately US$77,500.
- F2The shares of the Issuer's common stock are held by the Reporting Person's IRA.